Ticker | Value | Shares | Price | Security | Type | Insider | Title | Return | Flags | Date |
|---|---|---|---|---|---|---|---|---|---|---|
| No transactions found | ||||||||||
Jennifer A. Fox currently holds 125,000 shares of Apogee Therapeutics, Inc. (APGE), valued at approximately $0. This represents their equity stake as Executive.
Based on SEC Form 4 filings, Jennifer A. Fox has been a net neutral trader of APGE stock. They have purchased $0 and sold $0 worth of shares.
Jennifer A. Fox's most recent insider trade was on Jun 15, 2026, when they sold 125,000 shares at $0.00 per share.
Jennifer A. Fox serves as Executive at Apogee Therapeutics, Inc. (APGE). They have executed 8 insider transactions totaling $0 over their tenure at the company.
Jennifer A. Fox holds the position of Executive at Apogee Therapeutics, Inc., where they are responsible for executive-level decision-making and strategic oversight. They have been associated with the company for 2 years and currently hold a stake valued at $0.
Jennifer A. Fox has shown a balanced trading pattern, with $0 in total purchases and $0 in total sales across all transactions. Their most recent activity indicates a balanced approach to trading.
The largest transaction by Jennifer A. Fox was on Feb 5, 2026, when they purchased $21.3K worth of ZBIO shares. This transaction involved 1,592 shares at $13.35 per share.
Jennifer A. Fox currently owns 125,000 shares of Apogee Therapeutics, Inc. (APGE), with an estimated value of $0. This stake represents their equity holdings accumulated through purchases, awards, and option exercises.
All of Jennifer A. Fox's SEC Form 4 insider trading filings are tracked on this page. Each transaction links directly to the official SEC EDGAR filing. Jennifer A. Fox has 8 Form 4 filings on record as an insider at Apogee Therapeutics, Inc..
Set alerts for Jennifer A. Fox and 40,000+ other insiders.